VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics Ltd. will showcase its AI-enhanced cardiac ultrasound technology, capable of delivering MRI-quality heart measurements quickly and cost-effectively, at The Data Effect conference in Vancouver. The event will gather over 125 Canadian health care leaders to discuss advancements in AI and health care. The company’s VMS+ system, already in use in leading hospitals across Canada, the US, and Europe, promises to revolutionize cardiac imaging with compatibility across major echocardiography brands.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
